Article

Ophthalmologists, national associations in Argentina join WGA, WGPA initiative

World Glaucoma Day and World Glaucoma Patient Association activities in Argentina included open-clinic days in private and public institutions in addition to free control routines in public spaces such as shopping centers, city government areas, religious or community centers, and sport clubs.

Buenos Aires, Argentina-World Glaucoma Day (WGD) and World Glaucoma Patient Association (WGPA) activities in Argentina included open-clinic days in private and public institutions in addition to free control routines in public spaces such as shopping centers, city government areas, religious or community centers, and sport clubs. To spread information to the general population, a number of conferences and educational talks for patients were held, as well as a media campaign based on TV and radio.

Free IOP measurements were provided at hospitals/glaucoma services near Buenos Aires, including: Hospital de Clínicas, Hospital Durand, Hospital Oftalmológico Pedro Lagleyze, and Hospital Oftalmológico Santa Lucía. Educational conferences for patients were held at Hospital Santa Lucía and Hospital Durand.

In highly populated areas around the capital city, IOP measurements were provided at the Hospital General Interzonal de Agudos Evita Pueblo (Berazategui) and the Centro Asistencial Sábato (Berazategui). Some private institutions joined the initiative, including Sampaolesi Medical Center, Quilmes Eye Center, and Luis Pasteur Medical Center.

At the national level, similar activities were organized in the city of Mendoza (Province of Mendoza, Dr. Gomez Romeo and Dra. Carrasco) and Trelew (Province of Chubut), hosted by a glaucoma research foundation (Fundación para la Investigación del Glaucoma, Dra. Nazar).

The Consejo Argentino de Oftalmología (Argentine Council of Ophthalmology, CAO), one of the Argentinean professional associations, endorsed the WGD by promoting through all its channels these activities and encouraging individual and joint initiatives from its members.

It is estimated that in developing countries 90% of those persons with some degree of glaucoma ignore they have this asymptomatic disease. In this and future World Glaucoma Days, physicians in Argentina will be working toward the goal of undetected glaucoma below 20% in year 2020.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.